Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.
W M Gersony, G J Peckham, R C Ellison...
https://pubmed.ncbi.nlm.nih.gov/6343572Completed
Phase 3
Age: 0 - 1Year
All Genders
ID00000494
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2013-12-13
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the effects (up to one year of age) of indomethacin on the clinical course of patent ductus arteriosus (PDA) in premature infants (24 hours old or less) and to assess the relative merits of indomethacin and surgery in infants with persistent respiratory distress who were not treated early with indomethacin. Two concurrent trials were performed.
CONDITIONS
Official Title
Management of Patent Ductus in Premature Infants
Who Can Participate
Age: 0 - 1Year
All Genders
Eligibility Criteria
You may qualify if you...
Boy and girl premature infants with patent ductus arteriosus. Birth weight of 1,750 grams or less. Admitted to participating institution within first 24 hours of life.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Evaluation of the preterm infant for patent ductus arteriosus.
R C Ellison, G J Peckham, P Lang...
https://pubmed.ncbi.nlm.nih.gov/6338474Modified tarsorrhaphy versus gold weight implant technique for paralytic lagophthalmos treatment in patients with leprosy: One-year observation of a randomized controlled trial study.
Yunia Irawati, Michelle Eva Rebeca Natalia, Tjahjono D Gondhowiardjo...
https://pubmed.ncbi.nlm.nih.gov/36687442